Baidu
map

J CACHEXIA SARCOPENI:慢阻肺患者口服β-丙氨酸12周后的疗效

2022-09-05 小文子 MedSci原创

补充β-丙氨酸可有效增加 COPD 患者的肌肽,然而,未观察到伴随的运动能力、股四头肌功能和肌肉氧化/羰基应激的有益变化。

补充β-丙氨酸 (BA) 可增加肌肉肌肽,肌肽是骨骼肌中丰富的内源性抗氧化剂和 pH 缓冲液。肌肽负荷可促进健康老年人的运动能力。由于慢性阻塞性肺疾病 (COPD) 患者存在运动诱发的肌肉氧化/羰基应激和酸中毒,以及肌肉肌肽储备减少,Journal of Cachexia, Sarcopenia and Muscle杂志发表了一项研究,调查了补充β-丙氨酸是否会导致COPD患者增加肌肉肌肽,并诱导运动能力、股四头肌功能、肌肉氧化/羰基应激的有益变化。

40例 COPD 患者(75%为男性)(年龄65±6岁;FEV1%预测值55±14%)被分组接受12周口服β-丙氨酸或安慰剂补充剂(3.2 g/天)。主要结局,即肌肽,通过干预前后的股外侧肌活检来量化。还评估了协同主要结局,即增量和恒定的工作速率周期能力。进行了线性混合模型分析。还评估了补充剂摄入的依从性和副作用以及次要结局(股四头肌力量和耐力,以及肌肉氧化/羰基应激)。

结果显示,与安慰剂相比,补充β-丙氨酸增加了 COPD 患者的肌肉肌肽(平均差异 + 2.82[1.49~4.14]mmol/kg湿重;P < 0.001)。最大增量循环能力(VO2peak:+ 0.5[0.7~1.7]mL/kg/min;P = 0.384,Wpeak:+ 5[1~11]W;P = 0.103)和恒定功率循环试验的力竭时间(+ 28[179~236]s;P = 0.782)无显著变化。

β-丙氨酸组(中位数,100(98~100)%)和安慰剂组(98(96~100)%)(P = 0.294)对补充剂摄入的依从性相似,患者未报告可能与补充剂摄入相关的副作用。次要结局无变化。

与安慰剂相比,补充β-丙氨酸可有效增加 COPD 患者的肌肽(较平均基线值 + 54%),且无副作用。然而,未观察到伴随的运动能力、股四头肌功能和肌肉氧化/羰基应激的有益变化。

原文出处:

Jana De Brandt, Wim Derave, et al, Efficacy of 12 weeks oral beta-alanine supplementation in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled trial, Journal of Cachexia, Sarcopenia and Muscle (2022), DOI: 10.1002/jcsm.13048.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1729792, encodeId=e6401e297923c, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Dec 17 03:22:01 CST 2022, time=2022-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243364, encodeId=dcb6124336453, content=丙氨酸是形成肌肽的成分, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfb88268522, createdName=雪莲花啊, createdTime=Mon Sep 05 21:10:58 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243363, encodeId=9329124336393, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfb88268522, createdName=雪莲花啊, createdTime=Mon Sep 05 21:09:29 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541658, encodeId=49451541658b0, content=<a href='/topic/show?id=0d9239585e' target=_blank style='color:#2F92EE;'>#CAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3958, encryptionId=0d9239585e, topicName=CAC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=044f13304956, createdName=ms9651749636653578, createdTime=Sun Sep 04 11:22:01 CST 2022, time=2022-09-04, status=1, ipAttribution=)]
    2022-12-17 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1729792, encodeId=e6401e297923c, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Dec 17 03:22:01 CST 2022, time=2022-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243364, encodeId=dcb6124336453, content=丙氨酸是形成肌肽的成分, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfb88268522, createdName=雪莲花啊, createdTime=Mon Sep 05 21:10:58 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243363, encodeId=9329124336393, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfb88268522, createdName=雪莲花啊, createdTime=Mon Sep 05 21:09:29 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541658, encodeId=49451541658b0, content=<a href='/topic/show?id=0d9239585e' target=_blank style='color:#2F92EE;'>#CAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3958, encryptionId=0d9239585e, topicName=CAC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=044f13304956, createdName=ms9651749636653578, createdTime=Sun Sep 04 11:22:01 CST 2022, time=2022-09-04, status=1, ipAttribution=)]
    2022-09-05 雪莲花啊

    丙氨酸是形成肌肽的成分

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1729792, encodeId=e6401e297923c, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Dec 17 03:22:01 CST 2022, time=2022-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243364, encodeId=dcb6124336453, content=丙氨酸是形成肌肽的成分, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfb88268522, createdName=雪莲花啊, createdTime=Mon Sep 05 21:10:58 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243363, encodeId=9329124336393, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfb88268522, createdName=雪莲花啊, createdTime=Mon Sep 05 21:09:29 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541658, encodeId=49451541658b0, content=<a href='/topic/show?id=0d9239585e' target=_blank style='color:#2F92EE;'>#CAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3958, encryptionId=0d9239585e, topicName=CAC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=044f13304956, createdName=ms9651749636653578, createdTime=Sun Sep 04 11:22:01 CST 2022, time=2022-09-04, status=1, ipAttribution=)]
    2022-09-05 雪莲花啊

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1729792, encodeId=e6401e297923c, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Dec 17 03:22:01 CST 2022, time=2022-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243364, encodeId=dcb6124336453, content=丙氨酸是形成肌肽的成分, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfb88268522, createdName=雪莲花啊, createdTime=Mon Sep 05 21:10:58 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243363, encodeId=9329124336393, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfb88268522, createdName=雪莲花啊, createdTime=Mon Sep 05 21:09:29 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541658, encodeId=49451541658b0, content=<a href='/topic/show?id=0d9239585e' target=_blank style='color:#2F92EE;'>#CAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3958, encryptionId=0d9239585e, topicName=CAC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=044f13304956, createdName=ms9651749636653578, createdTime=Sun Sep 04 11:22:01 CST 2022, time=2022-09-04, status=1, ipAttribution=)]

相关资讯

Nutrients:43%的COPD稳定期患者存在能量营养不良

稳定期 COPD 患者存在能量营养不良,提示早期营养损害的可能性和早期营养干预的需要。

Lancet Respir Med:家庭氧疗可能对慢阻肺和中度低氧血症患者并无益处

研究调查家庭氧疗(LTOT或夜间氧疗)对 COPD 和中度低氧血症患者总生存期的影响。

Am J Respir Crit Care Med:高流量鼻导管治疗稳定期合并高碳酸血症COPD

研究评估了长期高流量鼻导管是否可以减少因慢性阻塞性肺疾病导致的慢性高碳酸血症呼吸衰竭患者的急性加重次数并改善其他生理参数。

ATS:通过远程监测和健康指导可提高COPD患者生活质量

远程监测与健康指导可促进 COPD患者健康和行为改变,是家庭康复的有效选择。

BMJ:1990-2019年间全球国家和地区慢阻肺疾病负担的系统分析

COPD的疾病负担不断减轻,但仍然是一个主要的公共卫生问题。

CHEST:慢阻肺单一吸入器与多重吸入器三联疗法,哪个更优?

开始SITT治疗的患者具有临床相关的持续性改善。

Baidu
map
Baidu
map
Baidu
map